Xenous Holdings (XITO) Financials
Newest figures come from the 10-Q for Q3 FY2026, filed Feb 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XITO SEC filings page.
This page shows Xenous Holdings Inc (XITO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Financial Health Signals
We do not publish a peer-relative financial health score for Xenous Holdings Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Xenous Holdings Inc reported a net loss of $16K in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Xenous Holdings Inc earned $0.00 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Not reported for Q3 2026.
Cash & Balance Sheet
Xenous Holdings Inc held $0 in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
None of these metrics is reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
XITO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $399+27.1% | $555-8.1% | $311-1.6% | $327+15.1% | $314-29.0% | $604+72.1% | $316-49.8% | $284-8.7% |
| Net Income | -$16Kn/m | -$16Kn/m | -$15Kn/m | -$18Kn/m | -$15Kn/m | -$15Kn/m | -$16Kn/m | -$18Kn/m |
| EPS (Diluted) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00 | $0.00 |
| Diluted Shares (Avg) | 760M0.0% | 760M0.0% | 760M0.0% | N/A | 760M0.0% | 760M0.0% | 760M | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Basic).
XITO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25Filing | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Cash & Equivalents | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $950K+7.3% | $935K+7.4% | $919K+7.5% | $904K+7.7% | $885K+7.8% | $870K+8.0% | $855K+8.1% | $839K+8.2% |
| Current Liabilities | $950K+7.3% | $935K+7.4% | $919K+7.5% | $904K+7.7% | $885K+7.8% | $870K+8.0% | $855K+8.1% | $839K+8.2% |
| Non-Current Liabilities | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Equity | -$950Kn/m | -$935Kn/m | -$919Kn/m | -$904Kn/m | -$885Kn/m | -$870Kn/m | -$855Kn/m | -$839Kn/m |
| Retained Earnings | -$1.3Mn/m | -$1.2Mn/m | -$1.2Mn/m | -$1.2Mn/m | -$1.2Mn/m | -$1.2Mn/m | -$1.2Mn/m | -$1.1Mn/m |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
XITO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
XITO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Current Ratio, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$904K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where Xenous Holdings Inc Ranks
Frequently Asked Questions
No, Xenous Holdings Inc (XITO) reported a net loss of $65K over the trailing 12 months to December 31, 2025. In fiscal year 2025 it reported a net loss of $64K.
Xenous Holdings Inc (XITO) recorded an outflow of $64K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Xenous Holdings Inc (XITO) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.
Xenous Holdings Inc (XITO) has negative shareholder equity of -$904K as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.